Sign in

CIK 0001279704

  • Non-accelerated filer
  • Smaller reporting company

Cellectar Biosciences, Inc.

Sign in to watch
Ticker
CLRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043321804
Phone
+1 608-441-8120
Business address
100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
Former names
NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-07 NEIS JOHN Director Grant or award · Stock option (right to buy) +25,000 25,000
2025-12-12 NEIS JOHN Director Sale −198 $3.70 $732 10
2025-02-14 NEIS JOHN Director Grant or award · Stock option (right to buy) +60,000 60,000
2024-06-14 NEIS JOHN Director Grant or award · Stock option (right to buy) +60,000 60,000
2023-06-28 NEIS JOHN Director Grant or award · Stock option (right to buy) +25,000 47,887
2022-06-24 NEIS JOHN Director Grant or award · Stock option (right to buy) +7,800 7,800
2021-06-30 NEIS JOHN Director Grant or award · Stock option (right to buy) +78,000 78,000
2021-03-18 NEIS JOHN Director Sale · Series A Warrants −23,232 $0.25 $6K 0
2021-03-17 NEIS JOHN Director Sale · Series A Warrants −58,640 $0.28 $16K 23,232
2021-03-16 NEIS JOHN Director Sale · Series A Warrants −100,515 $0.31 $31K 81,872
2021-03-15 NEIS JOHN Director Sale · Series A Warrants −11,200 $0.27 $3K 182,387
2021-03-12 NEIS JOHN Director Sale · Series A Warrants −41,155 $0.27 $11K 193,587
2020-06-24 NEIS JOHN Director Grant or award · Stock option (right to buy) +50,000 50,000
2019-06-13 NEIS JOHN Director Grant or award · Stock option (right to buy) +6,500 6,500
2018-10-12 NEIS JOHN Director Grant or award · Stock option (right to buy) +13,000 13,000
2017-11-14 NEIS JOHN Director Sale −5,214 $1.49 $8K 626,103
2017-05-31 NEIS JOHN Director Grant or award · Stock option (right to buy) +10,000 10,000
2016-11-29 NEIS JOHN Director Purchase +333,333 $1.49 $497K 631,317
2016-11-29 NEIS JOHN Director Purchase · Series C Warrants (right to buy) +333,333 $0.01 $3K 607,946
2016-07-05 NEIS JOHN Director Grant or award · Stock option (right to buy) +22,500 $0.01 $225 24,750

Page 1 of 2 · 29 trades